Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 43 results.
User Information
Export Records
  1. 1.   Recombinant OC43 SARS-CoV-2 spike replacement virus: An improved BSL-2 proxy virus for SARS-CoV-2 neutralization assays
  2. Hu, Zhe; López-Muñoz, Alberto Domingo; Kosik, Ivan; Li, Tiansheng; Callahan, Victoria; Brooks, Kelsie; Yee, Debra S; Holly, Jaroslav; Santos, Jefferson J S; Castro Brant,Ayslan; Johnson, Reed F; Takeda, Kazuyo; Zheng,Zhi-Ming; Brenchley, Jason M; Yewdell, Jonathan W; Fox, Julie M
  3. Proceedings of the National Academy of Sciences of the United States of America. 2024, Jul 16; 121(29): e2310421121.
  1. 2.   Mucosal correlates of protection after influenza viral challenge of vaccinated and unvaccinated healthy volunteers
  2. Bean, Rachel; Giurgea, Luca T; Han, Alison; Czajkowski, Lindsay; Cervantes-Medina, Adriana; Gouzoulis, Monica; Mateja,Allyson; Hunsberger, Sally; Reed, Susan; Athota, Rani; Baus, Holly Ann; Kash, John C; Park, Jaekeun; Taubenberger, Jeffery K; Memoli, Matthew J
  3. mBio. 2024, Jan 09; e0237223.
  1. 3.   Tumor-associated macrophages trigger MAIT cell dysfunction at the HCC invasive margin
  2. Ruf, Benjamin; Bruhns, Matthias; Babaei, Sepideh; Kedei, Noemi; Ma, Lichun; Revsine, Mahler; Benmebarek, Mohamed-Reda; Ma, Chi; Heinrich, Bernd; Subramanyam, Varun; Qi, Jonathan; Wabitsch, Simon; Green, Benjamin L; Bauer, Kylynda C; Myojin, Yuta; Greten, Layla T; McCallen, Justin D; Huang, Patrick; Trehan, Rajiv; Wang, Xin; Nur, Amran; Murphy Soika, Dana Qiang; Pouzolles, Marie; Evans, Christine N; Chari,Raj; Kleiner, David E; Telford, William; Dadkhah, Kimia; Ruchinskas, Allison; Stovroff, Merrill K; Kang, Jiman; Oza, Kesha; Ruchirawat, Mathuros; Kroemer, Alexander; Wang, Xin Wei; Claassen, Manfred; Korangy, Firouzeh; Greten, Tim F
  3. Cell. 2023, Aug 17; 186(17): 3686-3705.e32.
  1. 4.   The SeroNet Clinical and Translational Serology Task Force (CTTF) SARS-CoV-2 mucosal immunity methodological considerations and best practices workshop
  2. Hempel,Heidi; Mantis, Nicholas; Heaney, Christopher D; Pinto,Ligia
  3. Human Vaccines & Immunotherapeutics. 2023, Aug 01; 19(2): 2253598.
  1. 5.   Cross-neutralizing protection of vaginal and oral mucosa from HPV challenge by vaccination in a mouse model
  2. Sanders,Chelsea; Matthews,Rebecca; Esfahani, Sayyed Hamid Zarkesh; Khan,Nazneen; Patel,Nimit; Kalen,Joseph; Kirnbauer, Reinhard; Roden, Richard B; Difilippantonio,Simone; Pinto,Ligia; Shoemaker, Robert H; Marshall,Jason
  3. Vaccine. 2023, Jun 01;
  1. 6.   Comparison of levels of nasal, salivary, and plasma antibody to SARS-CoV-2 during natural infection and after vaccination
  2. Cohen, Jeffrey I; Dropulic, Lesia; Wang, Kening; Gangler, Krista; Morgan, Kayla; Liepshutz,Kelly; Krogmann, Tammy; Ali, Mir A; Qin, Jing; Wang,Jing; Vogel, Joshua S; Lei, Yona; Suzuki-Williams, Lui P; Spalding, Chris; Palmore, Tara N; Burbelo, Peter D
  3. Clinical Infectious Diseases : an official publication of the Infectious Diseases Society of America. 2022, Dec 09;
  1. 7.   An intranasally administrated SARS-CoV-2 beta variant subunit booster vaccine prevents beta variant replication in rhesus macaques
  2. Sui, Yongjun; Li, Jianping; Andersen, Hanne; Zhang, Roushu; Prabhu, Sunaina K; Hoang, Tanya; Venzon, David; Cook, Anthony; Brown, Renita; Teow, Elyse; Velasco, Jason; Pessaint, Laurent; Moore, Ian N; Lagenaur, Laurel; Talton, Jim; Breed,Matthew; Kramer,Josh; Bock, Kevin W; Minai, Mahnaz; Nagata, Bianca M; Choo-Wosoba, Hyoyoung; Lewis, Mark G; Wang, Lai-Xi; Berzofsky, Jay A
  3. PNAS Nexus. 2022, Jul; 1(3): pgac091.
  1. 8.   Efficacy of Cochleated Amphotericin B in Mouse and Human Mucocutaneous Candidiasis
  2. Desai, Jigar V; Urban,Amanda; Swaim,Doris; Colton, Benjamin; Kibathi, Lilian W; Ferrè, Elise M N; Stratton, Pamela; Merideth, Melissa A; Hunsberger, Sally; Matkovits, Theresa; Mannino, Raphael; Holland, Steven M; Tramont, Edmund; Lionakis, Michail S; Freeman, Alexandra F
  3. Antimicrobial Agents and Chemotherapy. 2022, Jun 14; e0030822.
  1. 9.   Environmental Pollutants, Mucosal Barriers, and Pathogen Susceptibility; The Case for Aflatoxin B-1 as a Risk Factor for HIV Transmission and Pathogenesis
  2. Madeen,Erin; Maldarelli,Frank; Groopman, John D.
  3. Pathogens. 2021, Sep 23; 10(10):
  1. 10.   A prime/boost vaccine regimen alters the rectal microbiome and impacts immune responses and viremia control post-SIV infection in male and female rhesus macaques
  2. Musich, Thomas; Thovarai, Vishal; Venzon, David J; Mohanram, Venkatramanan; Tuero, Iskra; Miller-Novak, Leia K; Helmold Hait, Sabrina; Rahman, Mohammad Arif; Hunegnaw, Ruth; Huiting, Erin; Yuan, Wuxing; O'hUigin, Colm; Hoang, Tanya; Sui, Yongjun; Labranche, Celia; Montefiori, David; Bear,Jenifer; Rosati,Margherita; Bissa, Massimiliano; Berzofsky, Jay A; Pavlakis,George; Felber,Barbara; Franchini, Genoveffa; Robert-Guroff, Marjorie
  3. Journal of virology. 2020, DEC; 94(24): pii: JVI.01225-20.
  1. 11.   Autoreactive T Cells and Chronic Fungal Infection Drive Esophageal Carcinogenesis
  2. Zhu, Feng; Willette Brown, Jami; Song, Na-Young; Lomada, Dakshayani; Song, Yongmei; Xue, Liyan; Gray, Zane; Zhao, Zitong; Davis, Sean R; Sun, David; Zhang, Peilin; Wu, Xiaolin; Zhan, Qimin; Richie, Ellen R; Hu, Yinling
  3. Cell Host & Microbe. 2017, Apr 12; 21(4): 478-493.e7.
  1. 12.   SIVmac239 MVA vaccine with and without a DNA prime, similar prevention of infection by a repeated dose SIVsmE660 challenge despite different immune responses
  2. Lai, L. L.; Kwa, S. F.; Kozlowski, P. A.; Montefiori, D. C.; Nolen, T. L.; Hudgens, M. G.; Johnson, W. E.; Ferrari, G.; Hirsch, V. M.; Felber, B. K.; Pavlakis, G. N.; Earl, P. L.; Moss, B.; Amara, R. R.; Robinson, H. L.
  3. Vaccine. 2012, Feb; 30(9): 1737-1745.
  1. 13.   Putative rhesus macaque germline predecessors of human broadly HIV-neutralizing antibodies: Differences from the human counterparts and implications for HIV-1 vaccine development
  2. Yuan, T. T.; Li, J. J.; Zhang, Y.; Wang, Y. P.; Streaker, E.; Dimitrov, D. S.; Zhang, M. Y.
  3. Vaccine. 2011, Sep; 29(40): 6903-6910.
  1. 14.   HSV-2 Infection of Dendritic Cells Amplifies a Highly Susceptible HIV-1 Cell Target
  2. Martinelli, E.; Tharinger, H.; Frank, I.; Arthos, J.; Piatak, M.; Lifson, J. D.; Blanchard, J.; Gettie, A.; Robbiani, M.
  3. Plos Pathogens. 2011, Jun; 7(6): 14.
  1. 15.   Distribution, Persistence, and Efficacy of Adoptively Transferred Central and Effector Memory-Derived Autologous Simian Immunodeficiency Virus-Specific CD8(+) T Cell Clones in Rhesus Macaques during Acute Infection
  2. Minang, J. T.; Trivett, M. T.; Bolton, D. L.; Trubey, C. M.; Estes, J. D.; Li, Y.; Smedley, J.; Pung, R.; Rosati, M.; Jalah, R.; Pavlakis, G. N.; Felber, B. K.; Piatak, M.; Roederer, M.; Lifson, J. D.; Ott, D. E.; Ohlen, C.
  3. Journal of Immunology. 2010, Jan; 184(1): 315-326.
  1. 16.   Partial protection against SIV challenge by vaccination of adenovirus and MVA vectors in rhesus monkeys
  2. Wang, H. B.; Kondo, A.; Yoshida, A.; Yoshizaki, S.; Abe, S.; Bao, L. L.; Mizuki, N.; Ichino, M.; Klinman, D.; Okuda, K.; Shimada, M.
  3. Gene Therapy. 2010, Jan; 17(1): 4-13.
  1. 17.   Tonsillar Application of AT-2 SIV Affords Partial Protection Against Rectal Challenge With SIVmac239
  2. Vagenas, P.; Williams, V. G.; Piatak, M.; Bess, J. W.; Lifson, J. D.; Blanchard, J. L.; Gettie, A.; Robbiani, M.
  3. Jaids-Journal of Acquired Immune Deficiency Syndromes. 2009 52(4): 433-442.
  1. 18.   Vaccine-Induced Cellular Responses Control Simian Immunodeficiency Virus Replication after Heterologous Challenge
  2. Wilson, N. A.; Keele, B. F.; Reed, J. S.; Piaskowski, S. M.; MacNair, C. E.; Bett, A. J.; Liang, X. P.; Wang, F. B.; Thoryk, E.; Heidecker, G. J.; Citron, M. P.; Huang, L. Y.; Lin, J.; Vitelli, S.; Ahn, C. D.; Kaizu, M.; Maness, N. J.; Reynolds, M. R.
  3. Journal of Virology. 2009 83(13): 6508-6521.
  1. 19.   DNA/MVA HIV-1/AIDS vaccine elicits long-lived vaccinia virus-specific immunity and confers protection against a lethal monkeypox challenge
  2. Nigam, P.; Earl, P. L.; Americo, J. L.; Sharma, S.; Wyatt, L. S.; Edghill-Spano, Y.; Chennareddi, L. S.; Silvera, P.; Moss, B.; Robinson, H. L.; Amara, R. R.
  3. Virology. 2007, Sep; 366(1): 73-83.
  1. 20.   Recombinant modified vaccinia virus Ankara provides durable protection against disease caused by an immunodeficiency virus as well as long-term immunity to an orthopoxvirus in a non-human primate
  2. Earl, P. L.; Americo, J. L.; Wyatt, L. S.; Eller, L. A.; Montefiori, D. C.; Byrum, R.; Piatak, M.; Lifson, J. D.; Amara, R. R.; Robinson, H. L.; Huggins, J. W.; Moss, B.
  3. Virology. 2007, Sep; 366(1): 84-97.
  1. 21.   IL-15 induces C4+ effector memory T cell production and tissue emigration in nonhuman primates
  2. Picker, L. J.; Reed-Inderbitzin, E. F.; Hagen, S. I.; Edgar, J. B.; Hansen, S. G.; Legasse, A.; Planer, S.; Piatak, M.; Lifson, J. D.; Maino, V. C.; Axthelm, M. K.; Villinger, F.
  3. Journal of Clinical Investigation. 2006, JUN; 116(6): 1514-1524.
  1. 22.   Human alpha-defensins block papillomavirus infection
  2. Buck, C. B.; Day, P. M.; Thompson, C. D.; Lubkowski, J.; Lu, W. Y.; Lowy, D. R.; Schiller, J. T.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2006, JAN 31; 103(5): 1516-1521.
  1. 23.   Both IL-12p70 and IL-23 are synthesized during active Crohn's disease and are down-regulated by treatment with anti-IL-12 p40 monoclonal antibody
  2. Fuss, I. J.; Becker, C.; Yang, Z. Q.; Groden, C.; Hornung, R. L.; Heller, F.; Neurath, M. F.; Strober, W.; Mannon, P. J.
  3. Inflammatory Bowel Diseases. 2006, JAN; 12(1): 9-15.
  1. 24.   Human beta-defensins suppress human immunodeficiency virus infection: Potential role in mucosal protection
  2. Sun, L. L.; Finnegan, C. M.; Kish-Catalone, T.; Blumenthal, R.; Garzino-Demo, P.; Maggiore, G. M. L.; Berrone, S.; Kleinman, C.; Wu, Z. B.; Abdelwahab, S.; Lu, W. Y.; Garzino-Demo, A.
  3. Journal of Virology. 2005, NOV; 79(22): 14318-14329.
  1. 25.   DNA vaccines expressing different forms of simian immunodeficiency virus antigens decrease viremia upon SIVmac251 challenge
  2. Rosati, M.; von Gegerfelt, A.; Roth, P.; Alicea, C.; Valentin, A.; Robert-Guroff, M.; Venzon, D.; Montefiori, D. C.; Markham, P.; Felber, B. K.; Pavlakis, G. N.
  3. Journal of Virology. 2005, JUL; 79(13): 8480-8492.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel